ICM
MRNA icon

Islay Capital Management’s Moderna MRNA Stock Holding History

Islay Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-643
Closed -$92K – 271
2022
Q2 		$92K Buy
643
+174
+37% +$24.9K 0.1% 143
2022
Q1 		$81K Buy
469
+104
+28% +$17.5K 0.07% 172
2021
Q4 		$93K Buy
+365
New +$107K 0.07% 163
2021
Q1 		– Sell
-40
Closed -$4K – 301
2020
Q4 		$4K Hold
40
– – ﹤0.01% 249
2020
Q3 		$3K Buy
+40
New +$2.79K ﹤0.01% 251

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Islay Capital Management's MRNA Position: Q3 2022 in Review

Islay Capital Management sold out of Moderna (MRNA) in Q3 2022, closing a stake of 643 shares — an estimated $92K sold.

Islay Capital Management first reported a position in MRNA in Q3 2020 and held it in 5 quarters. The position peaked at $93K in Q4 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Islay Capital Management reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Islay Capital Management sold 643 Moderna shares in Q3 2022, an estimated $92K.
  • Islay Capital Management first reported a position in Moderna in Q3 2020 and held it in 5 quarters.
  • Islay Capital Management's Moderna position peaked at $93K in Q4 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Islay Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.